World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
21346
World Ranking
1286
National Ranking
569

Roger J. Pomerantz publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Roger J. Pomerantz sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 259 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Roger J. Pomerantz D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Roger J. Pomerantz sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 78 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Roger J. Pomerantz is affiliated with ContraFect in the United States, contributing primarily to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work focuses on several subfields including Infectious Diseases, Epidemiology, Clinical Biochemistry, Surgery, and Molecular Biology.

The scientist's research intersects main topics such as Clostridium difficile and Clostridium perfringens research, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing, Microscopic Colitis, Helicobacter pylori-related gastroenterology studies, Infective Endocarditis Diagnosis and Management, and Gut microbiota and health.

Among their recent publications are:

  • SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial, 2020, Clinical Infectious Diseases
  • Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis, 2020, Journal of Clinical Investigation
  • A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis, 2020, Gastroenterology
  • Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT), 2024, Clinical Infectious Diseases

Frequent coauthors collaborating with Roger J. Pomerantz include:

  • Barbara McGovern
  • Christopher B. Ford
  • Matthew R. Henn
  • Edward J. O'Brien
  • Patricia Bernardo

The scientist has contributed multiple times to the following publication venues:

  • Clinical Infectious Diseases
  • Journal of Clinical Investigation
  • Gastroenterology

Roger J. Pomerantz is recognized as a member of the Association of American Physicians. Their academic output and collaborative efforts establish a profile with significant focus on infectious diseases, microbiome therapeutics, and bacterial resistance research.

Best Publications

  • The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

    Hui Zhang;Bin Yang;Roger J. Pomerantz;Chune Zhang

  • The challenge of finding a cure for HIV infection.

    Douglas D. Richman;David M. Margolis;Martin Delaney;Warner C. Greene

  • Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy

    Geethanjali Dornadula;Hui Zhang;Bonnie VanUitert;John Stern

  • Pathogenesis of infection with human immunodeficiency virus.

    David D. Ho;Roger J. Pomerantz;Joan C. Kaplan

  • Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy

    Zhang H;Dornadula G;Beumont M;Livornese L

  • Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

    Omar Bagasra;Ehud Lavi;Lisa Bobroski;Kamel Khalili

  • Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.

    Joseph A. DeSimone;Roger J. Pomerantz;Timothy J. Babinchak

  • Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

    Roger J. Pomerantz;Roger J. Pomerantz;Didier Trono;Mark B. Feinberg;David Baltimore

  • Antiviral Potentials of Medicinal Plants

    Muhammad Mukhtar;Mohammad Arshad;Mahmood Ahmad;Roger J. Pomerantz

  • Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

    Joseph Kulkosky;Derek M. Culnan;Jeanette Roman;Geethanjali Dornadula

  • Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction.

    Omar Bagasra;Stephen P. Hauptman;Harold W. Lischner;Mark Sachs

  • Twenty years of therapy for HIV-1 infection

    Roger J Pomerantz;David L Horn

  • IL-7 is a potent and proviral strain–specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART

    Feng-Xiang Wang;Yan Xu;Julie Sullivan;Emily Souder

  • A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

    Sahil Khanna;Darrell S. Pardi;Colleen R. Kelly;Colleen S. Kraft

  • Lipopolysaccharide Is a Potent Monocyte/Macrophage-specific Stimulator of Human Immunodeficiency Virus Type 1 Expression

    Roger J. Pomerantz;Mark B. Feinberg;Didier Trono;David Baltimore

  • Infection of the Retina by Human Immunodeficiency Virus Type I

    R J Pomerantz;D R Kuritzkes;S M de la Monte;T R Rota

  • Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis in Human Neuronal Cells

    Charvi A. Patel;Muhammad Mukhtar;Roger J. Pomerantz

  • Human Immunodeficiency Virus (HIV) Infection of the Uterine Cervix

    Roger J. Pomerantz;Suzanne M. de la Monte;S. Patrick Donegan;Teresa R. Rota

  • Central nervous system infections in individuals with HIV-1 infection

    Arunima Mamidi;Joseph A DeSimone;Roger J Pomerantz

  • Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men.

    Omar Bagasra;Homayoon Farzadegan;Thikkavarapu Seshamma;Joseph W. Oakes

Frequent Co-Authors

Omar Bagasra
Omar Bagasra Claflin University
Satoshi Kubota
Satoshi Kubota Okayama University
Matthias J. Schnell
Matthias J. Schnell Thomas Jefferson University
Bernhard Dietzschold
Bernhard Dietzschold Thomas Jefferson University
Kamel Khalili
Kamel Khalili Temple University
Matthew R. Henn
Matthew R. Henn Broad Institute
Masakazu Hatanaka
Masakazu Hatanaka Kyoto University
Mark A. Zern
Mark A. Zern University of California, Davis
Shohreh Amini
Shohreh Amini Temple University
Haruhiko Siomi
Haruhiko Siomi Keio University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens many doors, but it’s also worth exploring related fields that complement your knowledge. For those interested in healthcare administration, programs like the best fastest online medical billing and coding certificate programs offer quick certifications that can boost employability and provide foundational healthcare system expertise.

If you’re aiming to deepen your clinical knowledge with flexible study options, there are several well-paying medical degrees online that pay well. These degrees allow students to enter specialized medical fields without traditional on-campus constraints, combining both convenience and strong career prospects.

Public health is another pathway closely aligned with microbiology. Many students look for online MPH programs easy to get into to enhance their understanding of community health, epidemiology, and disease prevention. These programs are designed for accessibility and practical application in today’s global health landscape.

Finally, for those interested in direct patient support roles, becoming a child life specialist is rewarding both emotionally and financially. Learning how much does a child life specialist make can help you weigh the benefits of this career, which blends psychology, healthcare, and advocacy for young patients.

Best Scientists Citing Roger J. Pomerantz

Trending Scientists

Recently Published Articles